| pubmed-article:19712557 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19712557 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19712557 | lifeskim:mentions | umls-concept:C0004057 | lld:lifeskim |
| pubmed-article:19712557 | lifeskim:mentions | umls-concept:C0000809 | lld:lifeskim |
| pubmed-article:19712557 | lifeskim:mentions | umls-concept:C0085278 | lld:lifeskim |
| pubmed-article:19712557 | lifeskim:mentions | umls-concept:C0206460 | lld:lifeskim |
| pubmed-article:19712557 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19712557 | pubmed:dateCreated | 2009-8-28 | lld:pubmed |
| pubmed-article:19712557 | pubmed:abstractText | The aim of this retrospective, observational study was to determine the impact of low-dose enoxaparin (20 mg) in conjunction with low-dose aspirin on the pregnancy outcome of women with antiphospholipid syndrome and recurrent miscarriage. The study was conducted in a tertiary referral teaching hospital. A total of 35 women with antiphospholipid syndrome were treated with low-dose enoxaparin and aspirin as soon as pregnancy was confirmed. The outcome of pregnancy was analysed. The miscarriage rate was 7/35 (20%) whereas the live birth rate was 28/35 (80%). In conclusion, low-dose (20 mg) enoxaparin in conjunction with low-dose aspirin treatment produced encouraging results. The findings in this study suggest that there is a case for randomized controlled trials to compare low-dose (20 mg) enoxaparin with higher doses. | lld:pubmed |
| pubmed-article:19712557 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19712557 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19712557 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19712557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19712557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19712557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19712557 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19712557 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:19712557 | pubmed:issn | 1472-6491 | lld:pubmed |
| pubmed-article:19712557 | pubmed:author | pubmed-author:LiT CTC | lld:pubmed |
| pubmed-article:19712557 | pubmed:author | pubmed-author:MakrisMikeM | lld:pubmed |
| pubmed-article:19712557 | pubmed:author | pubmed-author:MetwallyMosta... | lld:pubmed |
| pubmed-article:19712557 | pubmed:author | pubmed-author:MoDavidD | lld:pubmed |
| pubmed-article:19712557 | pubmed:author | pubmed-author:SaravelosSoti... | lld:pubmed |
| pubmed-article:19712557 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19712557 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:19712557 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19712557 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19712557 | pubmed:pagination | 216-20 | lld:pubmed |
| pubmed-article:19712557 | pubmed:dateRevised | 2010-1-10 | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:meshHeading | pubmed-meshheading:19712557... | lld:pubmed |
| pubmed-article:19712557 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19712557 | pubmed:articleTitle | Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin. | lld:pubmed |
| pubmed-article:19712557 | pubmed:affiliation | Faculty of Pharmaceutical Sciences, University of British Colombia, Vancouver, Canada. | lld:pubmed |
| pubmed-article:19712557 | pubmed:publicationType | Journal Article | lld:pubmed |
